Ornithine decarboxylase activity in prostate cancer.
Sign Up to like & getrecommendations! Published in 2021 at "Experimental oncology"
DOI: 10.32471/exp-oncology.2312-8852.vol-43-no-1.16011
Abstract: Prostate cancer (PCa), the most common solid malignant neoplasm in men, is characterized using the Gleason score and diagnosed using prostate-specific antigen (PSA) biomarker. However, Gleason score and PSA-based diagnostics are not universal and have… read more here.
Keywords: aodc; prostate; decarboxylase activity; ornithine decarboxylase ... See more keywords